phase readout

NCT07568730: A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

RECRUITINGupdated 12m ago

community read0 votes

Sponsor: TearSolutions, Inc.. Phase: PHASE2. Conditions: Neurotrophic Keratitis

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 12m ago

Found something off?